Annual Drug Patent Expirations for ICLUSIG
Iclusig is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
Drug patent litigation for ICLUSIG.
This drug has eigthy-two patent family members in twenty-three countries.
The generic ingredient in ICLUSIG is ponatinib hydrochloride. One supplier is listed for this compound. Additional details are available on the ponatinib hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
